Durations of opioid, nonopioid drug, and behavioral clinical trials for chronic pain: Adequate or inadequate?

Pain Medicine (United States)

Volumn 17, Issue 11, 2016, Pages 2036-2046

  Tayeb, Baraa O ^a,b   Barreiro, Ana E ^a   Bradshaw, Ylisabyth S ^a   Chui, Kenneth K H ^a   Carr, Daniel B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b King Abdulaziz University   (Saudi Arabia)

Author keywords

Anticonvulsants; Antidepressants; Behavioral; Chronic Pain; NSAIDs; Opioids

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; OPIATE; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; ARTICLE; CHRONIC PAIN; DESCRIPTIVE RESEARCH; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; OPEN STUDY; POPULATION RESEARCH; PRACTICE GUIDELINE; SYSTEMATIC REVIEW; TREATMENT DURATION; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; DRUG ADMINISTRATION; PROCEDURES; PSYCHOLOGY;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CHRONIC PAIN; CLINICAL TRIALS AS TOPIC; COGNITIVE THERAPY; DRUG ADMINISTRATION SCHEDULE; HUMANS;

EID: 85019921845     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1093/PM/PNW245     Document Type: Article

References (76)

1. Homer. The Odyssey. 1st ed. New York: Farrar, Straus and Giroux; 1998
2. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16(5):405-16
3. Volkow ND, McLellan AT. Opioid abuse in chronic pain-misconceptions and mitigation strategies. N Engl J Med 2016;374(13):1253-63
4. Carr DB. "Pain is a public health problem"-what does that mean and why should we care? Pain Med 2016;17(4):626-7
5. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016 MMWR Recomm Rep 2016;65(1):1-49
6. Chou R, Deyo R, Devine B, et al. The effectiveness and risks of long-term opioid treatment of chronic pain. Evidence report/technology assessment No. 218 AHRQ publication No. 14-E005-EF. Rockville, MD: Agency for Healthcare Research and Quality; September 2014. www.effectivehealthcare.ahrq.gov/reports/final.cfm (accessed June 2016)
7. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-30
8. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010;1:CD006605
9. Cochrane Database of Systematic Reviews. Available at: http://www.cochranelibrary.com/cochrane-database-of-systematic-reviews/index.html (accessed June 2016)
10. Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012;7:CD008943
11. Chaparro LE, Furlan AD, Deshpande A, et al. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev 2013;8:CD004959
12. Gaskell H, Moore RA, Derry S, Stannard C. Oxycodone for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;6: CD010692
13. Haroutounian S, McNicol ED, Lipman AG. Methadone for chronic non-cancer pain in adults. Cochrane Database Syst Rev 2012;11:CD008025. [23152251]
14. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev 2013;8:CD006146
15. Quigley C. Hydromorphone for acute and chronic pain. Cochrane Database Syst Rev 2013;10: CD003447
16. Santos J, Alarcão J, Fareleira F, Vaz-Carneiro A, Costa J. Tapentadol for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2015;5: CD009923
17. Wrzosek A, Woron J, Dobrogowski J, Jakowicka-Wordliczek J, Wordliczek J. Topical clonidine for neuropathic pain. Cochrane Database Syst Rev 2015;8:CD010967
18. Aboumarzouk OM, Nelson RL. Pregabalin for chronic prostatitis. Cochrane Database Syst Rev 2012;8:CD009063
19. Gurusamy KS, Lusuku C, Davidson BR. Pregabalin for decreasing pancreatic pain in chronic pancreatitis. Cochrane Database Syst Rev 2016;2: CD011522
20. Gill D, Derry S, Wiffen PJ, Moore RA. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011;10:CD009183
21. Hearn L, Derry S, Moore RA. Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012;2:CD009318
22. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 2009;3:CD007076
23. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;4:CD007938
24. Moore RA, Wiffen PJ, Derry S, Lunn MP. Zonisamide for neuropathic pain in adults. Cochrane Database Syst Rev 2015;1:CD011241
25. Mujakperuo HR, Watson M, Morrison R, Macfarlane TV. Pharmacological interventions for pain in patients with temporomandibular disorders. Cochrane Database Syst Rev 2010;10:CD00471
26. Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev 2013;10:CD010782
27. Wiffen PJ, Derry S, Moore RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2013;12: CD006044
28. Wiffen PJ, Derry S, Lunn MP, Moore RA. Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2013;8: CD008314
29. Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;4:CD005451
30. Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2015;10:CD008244
31. Derry S, Phillips T, Moore RA, Wiffen PJ. Milnacipran for neuropathic pain in adults. Cochrane Database Syst Rev 2015;7:CD011789
32. Derry S, Wiffen PJ, Aldington D, Moore RA. Nortriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015;1:CD011209
33. Gallagher HC, Gallagher RM, Butler M, Buggy DJ, Henman MC. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev 2015;8: CD011091
34. Häuser W, Urrutia G, Tort S, Üçeyler N, Walitt B. Serotonin and noradrenaline reuptake inhibitors (snris) for fibromyalgia syndrome. Cochrane Database Syst Rev 2013;1:CD010292
35. Hearn L, Derry S, Phillips T, Moore RA, Wiffen PJ. Imipramine for neuropathic pain in adults. Cochrane Database Syst Rev 2014;5:CD010769
36. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014;1: CD007115
37. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015;7:CD008242
38. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007;4: CD005454
39. Tort S, Urrutia G, Nishishinya MB, Walitt B. Monoamine oxidase inhibitors (maois) for fibromyalgia syndrome. Cochrane Database Syst Rev 2012;4 :CD009807
40. Urquhart DM, Hoving JL, Assendelft WW, Roland M, van Tulder MW. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev 2008;1 :CD001703
41. Walitt B, Urrutia G, Nishishinya MB, Cantrell SE, Häuser W. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 2015;6:CD011735
42. Garner SE, Fidan D, Frankish RR, Maxwell L. Rofecoxib for osteoarthritis. Cochrane Database Syst Rev 2005;1:CD005115
43. Moore RA, Chi C-C, Wiffen PJ, Derry S, Rice AS. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev 2015;10: CD010902
44. Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008;1:CD000396
45. Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2012;9:CD010111
46. Derry S, Matthews PRL, Wiffen PJ, Moore RA. Salicylate-containing rubefacients for acute and chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2014;11:CD007403
47. Anie KA, Green J. Psychological therapies for sickle cell disease and pain. Cochrane Database Syst Rev 2015;5:CD001916
48. Bernardy K, Klose P, Busch AJ, Choy EHS, Häuser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev 2013;9:CD009796
49. Boldt I, Eriks-Hoogland I, Brinkhof MWG, et al. Nonpharmacological interventions for chronic pain in people with spinal cord injury. Cochrane Database Syst Rev 2014;11:CD009177
50. Eccleston C, Palermo TM, Williams ACdC, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev 2014;5: CD003968
51. Eccleston C, Fisher E, Craig L, et al. Psychological therapies (internet-delivered) for the management of chronic pain in adults. Cochrane Database Syst Rev 2014;2:CD010152
52. Fisher E, Law E, Palermo TM, Eccleston C. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev 2015;3:CD011118
53. Henschke N, Ostelo RWJG, van Tulder MW, et al. Behavioural treatment for chronic low-back pain. Cochrane Database Syst Rev 2010;7:CD002014
54. Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev 2014;9:CD000963
55. Karjalainen KA, Malmivaara A, van Tulder MW, et al. Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev 1999;3:CD001984
56. Karjalainen KA, Malmivaara A, van Tulder MW, et al. Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults. Cochrane Database Syst Rev 2003;2:CD002194
57. Monticone M, Cedraschi C, Ambrosini E, et al. Cognitive-behavioural treatment for subacute and chronic neck pain. Cochrane Database Syst Rev 2015;5:CD010664
58. Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev 2008;3: CD001027
59. Theadom A, Cropley M, Smith HE, Feigin VL, McPherson K. Mind and body therapy for fibromyalgia. Cochrane Database Syst Rev 2015;4: CD001980
60. Williams ACdC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2012;11:CD007407
61. Cochrane Handbook of Systematic Reviews of Interventions 2011. 2011. Available at: www. cochrane-handbook.org (accessed June 2016)
62. Stata online manual. Available at: http://www.stata. com/support/faqs/statistics/overdispersion-and-ex cess-zeros/(accessed July 5, 2016)
63. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 2012;153(6):1148-58
64. Dworkin RH, Turk DC, Peirce-Sandner S, et al. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010;149(2):177-93
65. U.S. Department of Health and Human Services, Food Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry analgesic indications: Developing drug and biological products. Draft guidance. 2014. Available at: http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM384691.pdf (accessed June 2016)
66. Committee for Medicinal Products for Human Use, European Medicines Agency. Guideline on the clinical development of medicinal products intended for the treatment of pain. 2nd draft. 2015. Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2015/12/WC500199242.pdf (accessed June 2016)
67. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. The extent of population exposure to assess clinical safety for drugs intended for longterm treatment of non-life-threatening conditions E1. 1994. Available at: http://www.ich.org/filead min/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E1/Step4/E1_Guideline.pdf (accessed June 2016)
68. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention workshop. Ann Intern Med 2015;162:276-86
69. Wittink HM, Carr DB, eds. Pain Management: Evidence, Outcomes, and Quality of Life. New York: Elsevier; 2008
70. West S, King V, Carey TS, et al. Systems to Rate the Strength of Scientific Evidence. Evidence report/technology assessment No.47. AHRQ publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality; 2002
71. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: An update for clinicians: A scientific statement from the American Heart Association. Circulation 2007;115:1634-42
72. Solomon DH, Raassen JA, Glynn RJ, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170:1968-76
73. Scarpignato C, Lanas A, Blandizzi C, et al. Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis-An expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks. BMC Med 2015;13:55
74. Simon LS. Non-steroidal anti-inflammatory drugs and their benefits and harms: The challenge of interpreting meta-analyses and observational data sets when balanced data are not analyzed and reported. Arthritis Res Ther 2015; 17(1):130
75. US Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. 2015. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm451800.htm76 (accessed June 2016)
76. The National Institutes of Health. The Interagency Pain Research Coordinating Committee. http://iprcc. nih.gov/National_Pain_Strategy/NPS_Main.htm (accessed March 2016)